Literature DB >> 24202787

Recessive dystonia-ataxia syndrome in a Turkish family caused by a COX20 (FAM36A) mutation.

Sarah Doss1, Katja Lohmann, Philip Seibler, Björn Arns, Thomas Klopstock, Christine Zühlke, Karen Freimann, Susen Winkler, Thora Lohnau, Mario Drungowski, Peter Nürnberg, Karin Wiegers, Ebba Lohmann, Sadaf Naz, Meike Kasten, Georg Bohner, Alfredo Ramirez, Matthias Endres, Christine Klein.   

Abstract

DYTCA is a syndrome that is characterized by predominant dystonia and mild cerebellar ataxia. We examined two affected siblings with healthy, consanguineous, Turkish parents. Both patients presented with a combination of childhood-onset cerebellar ataxia, dystonia, and sensory axonal neuropathy. In the brother, dystonic features were most pronounced in the legs, while his sister developed torticollis. Routine diagnostic investigations excluded known genetic causes. Biochemical analyses revealed a mitochondrial respiratory chain complex IV and a coenzyme Q10 deficiency in a muscle biopsy. By exome sequencing, we identified a homozygous missense mutation (c.154A >C; p.Thr52Pro) in both patients in exon 2 of the COX20 (FAM36A) gene, which encodes a complex IV assembly factor. This variant was confirmed by Sanger sequencing, was heterozygous in both parents, and was absent from 427 healthy controls. The exact same mutation was recently reported in a patient with ataxia and muscle hypotonia. Among 128 early-onset dystonia and/or ataxia patients, we did not detect any other patient with a COX20 mutation. cDNA sequencing and semi-quantitative analysis were performed in fibroblasts from one of our homozygous mutation carriers and six controls. In addition to the exchange of an amino acid, the mutation led to a shift in splicing. In conclusion, we extend the phenotypic spectrum of a recently identified mutation in COX20 to a recessively inherited, early-onset dystonia-ataxia syndrome that is characterized by reduced complex IV activity. Further, we confirm a pathogenic role of this mutation in cerebellar ataxia, but this mutation seems to be a rather rare cause.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24202787     DOI: 10.1007/s00415-013-7177-7

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  17 in total

Review 1.  The many clinical faces of cytochrome c oxidase deficiency.

Authors:  Salvatore DiMauro; Kurenai Tanji; Eric A Schon
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

2.  Impaired complex IV activity in response to loss of LRPPRC function can be compensated by mitochondrial hyperfusion.

Authors:  Stéphane G Rolland; Elisa Motori; Nadin Memar; Jürgen Hench; Stephan Frank; Konstanze F Winklhofer; Barbara Conradt
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-22       Impact factor: 11.205

Review 3.  Movement disorders in spinocerebellar ataxias.

Authors:  Judith van Gaalen; Paola Giunti; Bart P van de Warrenburg
Journal:  Mov Disord       Date:  2011-03-02       Impact factor: 10.338

4.  Mitochondrial network complexity and pathological decrease in complex I activity are tightly correlated in isolated human complex I deficiency.

Authors:  Werner J H Koopman; Henk-Jan Visch; Sjoerd Verkaart; Lambertus W P J van den Heuvel; Jan A M Smeitink; Peter H G M Willems
Journal:  Am J Physiol Cell Physiol       Date:  2005-05-18       Impact factor: 4.249

5.  Performance of mutation pathogenicity prediction methods on missense variants.

Authors:  Janita Thusberg; Ayodeji Olatubosun; Mauno Vihinen
Journal:  Hum Mutat       Date:  2011-02-22       Impact factor: 4.878

Review 6.  Slowly progressive cerebellar ataxia and cervical dystonia: clinical presentation of a new form of spinocerebellar ataxia?

Authors:  Mikko Kuoppamäki; Paula Giunti; Niall Quinn; Nicholas W Wood; Kailash P Bhatia
Journal:  Mov Disord       Date:  2003-02       Impact factor: 10.338

Review 7.  Movement disorders in neuro-metabolic diseases.

Authors:  Neziha Gouider-Khouja; Ichraf Kraoua; Hanene Benrhouma; Narjes Fraj; Aida Rouissi
Journal:  Eur J Paediatr Neurol       Date:  2009-12-16       Impact factor: 3.140

8.  A mutation in the FAM36A gene, the human ortholog of COX20, impairs cytochrome c oxidase assembly and is associated with ataxia and muscle hypotonia.

Authors:  Radek Szklarczyk; Bas F J Wanschers; Leo G Nijtmans; Richard J Rodenburg; Johannes Zschocke; Nicola Dikow; Mariël A M van den Brand; Marthe G M Hendriks-Franssen; Christian Gilissen; Joris A Veltman; Marco Nooteboom; Werner J H Koopman; Peter H G M Willems; Jan A M Smeitink; Martijn A Huynen; Lambertus P van den Heuvel
Journal:  Hum Mol Genet       Date:  2012-11-02       Impact factor: 6.150

9.  A mitochondrial encephalomyopathy: the first case with an established defect at the level of coenzyme Q.

Authors:  J C Fischer; W Ruitenbeek; F J Gabreëls; A J Janssen; W O Renier; R C Sengers; A M Stadhouders; H J ter Laak; J M Trijbels; J H Veerkamp
Journal:  Eur J Pediatr       Date:  1986-02       Impact factor: 3.183

10.  Mutant Parkin impairs mitochondrial function and morphology in human fibroblasts.

Authors:  Anne Grünewald; Lisa Voges; Aleksandar Rakovic; Meike Kasten; Himesha Vandebona; Claudia Hemmelmann; Katja Lohmann; Slobodanka Orolicki; Alfredo Ramirez; Anthony H V Schapira; Peter P Pramstaller; Carolyn M Sue; Christine Klein
Journal:  PLoS One       Date:  2010-09-27       Impact factor: 3.240

View more
  20 in total

Review 1.  Movement disorders in mitochondrial disease.

Authors:  Roula Ghaoui; Carolyn M Sue
Journal:  J Neurol       Date:  2018-01-06       Impact factor: 4.849

Review 2.  Genetic landscape remodelling in spinocerebellar ataxias: the influence of next-generation sequencing.

Authors:  Marie Coutelier; Giovanni Stevanin; Alexis Brice
Journal:  J Neurol       Date:  2015-04-11       Impact factor: 4.849

Review 3.  Building the CuA site of cytochrome c oxidase: A complicated, redox-dependent process driven by a surprisingly large complement of accessory proteins.

Authors:  Kimberly A Jett; Scot C Leary
Journal:  J Biol Chem       Date:  2017-09-29       Impact factor: 5.157

4.  A mutation of MET, encoding hepatocyte growth factor receptor, is associated with human DFNB97 hearing loss.

Authors:  Ghulam Mujtaba; Julie M Schultz; Ayesha Imtiaz; Robert J Morell; Thomas B Friedman; Sadaf Naz
Journal:  J Med Genet       Date:  2015-05-04       Impact factor: 6.318

5.  Observation of novel COX20 mutations related to autosomal recessive axonal neuropathy and static encephalopathy.

Authors:  Hongliang Xu; Tuo Ji; Yajun Lian; Shuya Wang; Xin Chen; Shuang Li; Yuhui Yin; Xiubing Dong
Journal:  Hum Genet       Date:  2019-05-11       Impact factor: 4.132

6.  Human COX20 cooperates with SCO1 and SCO2 to mature COX2 and promote the assembly of cytochrome c oxidase.

Authors:  Myriam Bourens; Aren Boulet; Scot C Leary; Antoni Barrientos
Journal:  Hum Mol Genet       Date:  2014-01-08       Impact factor: 5.121

7.  Ribosome-Associated Mba1 Escorts Cox2 from Insertion Machinery to Maturing Assembly Intermediates.

Authors:  Isotta Lorenzi; Silke Oeljeklaus; Christin Ronsör; Bettina Bareth; Bettina Warscheid; Peter Rehling; Sven Dennerlein
Journal:  Mol Cell Biol       Date:  2016-10-28       Impact factor: 4.272

8.  Needs and Requirements of Modern Biobanks on the Example of Dystonia Syndromes.

Authors:  Ebba Lohmann; Thomas Gasser; Kathrin Grundmann
Journal:  Front Neurol       Date:  2017-01-30       Impact factor: 4.003

Review 9.  Systematic review of autosomal recessive ataxias and proposal for a classification.

Authors:  Marie Beaudin; Christopher J Klein; Guy A Rouleau; Nicolas Dupré
Journal:  Cerebellum Ataxias       Date:  2017-02-23

10.  The mitochondrial TMEM177 associates with COX20 during COX2 biogenesis.

Authors:  Isotta Lorenzi; Silke Oeljeklaus; Abhishek Aich; Christin Ronsör; Sylvie Callegari; Jan Dudek; Bettina Warscheid; Sven Dennerlein; Peter Rehling
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2017-11-16       Impact factor: 4.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.